Table: begin end state 1 19 cytoplasmic 20 38 transmembrane 39 56 non-cytoplasmic 57 78 transmembrane 79 89 cytoplasmic 90 136 transmembrane 137 156 cytoplasmic 157 174 transmembrane 175 179 non-cytoplasmic 180 198 transmembrane 199 243 cytoplasmic 244 264 transmembrane 265 275 non-cytoplasmic 276 301 transmembrane 302 312 cytoplasmic 313 332 transmembrane 333 337 non-cytoplasmic 338 359 transmembrane 360 371 cytoplasmic 372 394 transmembrane 395 401 non-cytoplasmic 402 422 transmembrane 423 455 cytoplasmic
Input: >WP_012385184.1 NCBI__GCF_000019845.1:WP_012385184.1 MAAGFQGGLVQAAKRTATTTTGRVFGLICLMYFITYVDRVNVSTLAPLMSKELGLSNIQL GLVLSAFGYPYALLQILGGTAADKFGARKTLTICGGIWALSTIATGFVGGLFSLLLVRIF VGIGEGATFPAATRAMASWVPESRRGYAQGMVHSASRLANAITPPLVILIAAYLGWRGAF LALGCVSMVWVLAWLFYFRDNPRDHTGVSLQEIALLPEPRQKTQAGAVKVPWGPLTRAMM PTTLVYFCYNWTFWLYITWLPSYFVQAYGLELKHMAAFTFAIFAAGVVGDTLGGVLTDFV YHRTGDLPASRRLVVVFSLIASMICLIPALFVHDLVTIGFSLASAFFFLELTVGPIWAVP MDIAPHFSGTASGIMNTGSAIAGIVSPIAFGLVIDLTHSYTLPFYGSVLLLMIGACIAFF FMPSRGLVASSATENATTGQANSPRISTMRDVAGQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server